Wall Street Sees 84% Upside in Hims & Hers (HIMS) Despite This Months 48% Selloff Hims & Hers Health (NYSE:HIMS) has crashed 47.96% over the past month, falling from $31.32 on January 14 to $16.30…
Hims & Hers Health Stock (HIMS) Opinions on Earnings Beat Earnings surge ignites debate: Hims & Hers Health reported robust quarterly results, fueling widespread chatter on social media. Investors praised…
Hims & Hers is a brave bet on solving the disruptor’s dilemma Plan to make longevity affordable means muscling in on territory occupied by drugs giants and pharmacies…
Hims & Hers Health (HIMS) Is Down 29.2% After Semaglutide Lawsuit And DOJ Referral - Has The Bull Case Changed? Earlier in February 2026, Novo Nordisk sued Hims & Hers Health over its compounded semaglutide products, following the rapid launch…
Acadia Healthcare, Hims & Hers Health, RadNet, Halozyme Therapeutics, and Privia Health Shares Are Soaring, What You Need To Know A number of stocks jumped in the afternoon session after a softer-than-expected inflation report fueled hopes for interest rate cuts…
Hims & Hers short interest climbs amid legal risk related to weight loss pill Hims & Hers (HIMS) stock gains as short interest against the company climbs after a lawsuit from Novo Nordisk (NVO)…
Hims & Hers Shorts Up $1.3 Billion This Year on Legal Risk A rout in Hims & Hers Health Inc. has delivered a windfall to short sellers, as investors bet against the…
Hedge funds bet big against Hims & Hers Health before Wegovy showdown, Hazeltree data shows By Nell Mackenzie and Samuel Indyk LONDON, Feb 13 (Reuters) - Hedge fund bets against Hims & Hers Health hit…
Hedge funds bet big against Hims & Hers Health before Wegovy showdown, Hazeltree data shows Hedge fund bets against Hims & Hers Health hit their highest in at least a year in January, just before…
Hedge funds bet big against Hims & Hers Health before Wegovy showdown, Hazeltree data shows By Nell Mackenzie and Samuel Indyk Hedge fund bets against Hims & Hers Health hit their highest…